Recent Finacing
Recent Raise
BioAtla is a clinical-stage biotech developing Conditionally Active Biologic (CAB) antibody therapeutics that activate in diseased microenvironments, producing mAbs, ADCs, bispecifics, immune checkpoint inhibitors and CAR‑T therapies.
